Editorial: time to eat? Skipping breakfast in metabolic-associated fatty liver disease-Authors' reply

被引：0
|
作者：
Xie, Jiarong [1 ,2 ]
Xu, Lei [1 ,2 ]
Xu, Chengfu [2 ]
机构：
[1] Ningbo First Hosp, Dept Gastroenterol, Ningbo, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, Dept Gastroenterol, Sch Med, Hangzhou, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2022年 / 55卷 / 04期
关键词：
D O I：
10.1111/apt.16773
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：494 / 494
页数：1
相关论文
共 50 条
  • [21] Metabolic-associated fatty liver disease (MAFLD) in coeliac disease
    Rispo, Antonio
    Imperatore, Nicola
    Guarino, Maria
    Tortora, Raffaella
    Alisi, Anna
    Cossiga, Valentina
    Testa, Anna
    Ricciolino, Simona
    Fiorentino, Andrea
    Morisco, Filomena
    LIVER INTERNATIONAL, 2021, 41 (04) : 788 - 798
  • [22] Metabolic-associated fatty liver disease and the risk of cardiovascular disease
    Zhang, Pengwei
    Dong, Xianhui
    Zhang, Wei
    Wang, Shiyin
    Chen, Chen
    Tang, Jiake
    You, Yao
    Hu, Siqi
    Zhang, Shenghui
    Wang, Chunyi
    Wen, Wen
    Zhou, Mengyun
    Tan, Tao
    Qi, Guanming
    Li, Li
    Wang, Mingwei
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (01)
  • [23] Nonalcoholic Fatty Liver Disease Without Metabolic-associated Fatty Liver Disease and the Risk of Metabolic Syndrome
    Sinn, Dong Hyun
    Kang, Danbee
    Choi, Sung Chul
    Hong, Yun Soo
    Zhao, Di
    Guallar, Eliseo
    Park, Yewan
    Cho, Juhee
    Gwak, Geum-Youn
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (07) : 1873 - +
  • [24] Comparing patients with metabolic-associated fatty liver disease alone and patients with both chronic hepatitis C and metabolic-associated fatty liver disease
    Al Omary, A.
    Byth, K.
    Weltman, M.
    George, J.
    Eslam, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 45 - 46
  • [25] Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease
    Danielsson, Oscar
    Vesterinen, Tiina
    Arola, Johanna
    Aberg, Fredrik
    Nissinen, Markku J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (07) : 961 - 969
  • [26] Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' reply
    Christensen, B.
    Gibson, P. R.
    Rubin, D. T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (10) : 1423 - 1424
  • [27] Crystalising the burden of steatotic liver disease-Authors' reply
    Schneider, Carolin V.
    Schneider, Kai Markus
    Loomba, Rohit
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (10) : 1294 - 1295
  • [28] Metabolic-Associated Fatty Liver Disease and Diabetes A Double Whammy
    Kapoor, Nitin
    Kalra, Sanjay
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (03) : 469 - 484
  • [29] Metabolic-associated fatty liver disease and sarcopenia: A double whammy
    Viswanath, Aditya
    Fouda, Sherouk
    Fernandez, Cornelius James
    Pappachan, Joseph M.
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (02) : 152 - 163
  • [30] Management of metabolic-associated fatty liver disease: The diabetology perspective
    Mohammad Sadiq Jeeyavudeen
    Shahanas K A Khan
    Sherouk Fouda
    Joseph M Pappachan
    World Journal of Gastroenterology, 2023, 29 (01) : 126 - 143
12345